- Home
- CASI vs PURR Comparison
CASI vs PURR Comparison
Compare CASI & PURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.75
N/A
Current Price
$3.35
Company Overview
Basic Information| Metric | CASI | PURR |
|---|---|---|
| Founded | 1991 | 2025 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9M | 24.9M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CASI | PURR |
|---|---|---|
| Price | $0.75 | $3.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $5.00 |
| AVG Volume (30 Days) | 33.4K | ★ 1.6M |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,846,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.72 | N/A |
| 52 Week Low | $0.80 | $3.15 |
| 52 Week High | $3.47 | $4.65 |
Technical Indicators
Market Signals| Indicator | CASI | PURR |
|---|---|---|
| Relative Strength Index (RSI) | 26.78 | N/A |
| Support Level | $0.83 | N/A |
| Resistance Level | $0.95 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 5.95 | 0.00 |
Price Performance
Historical Comparison CASI
PURR
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.